Acute Lymphoblastic Leukemia Data and Case Discussion on the Use of Asparaginase Therapy in Young and Older Adults

Download All
Gain expert guidance on how to optimally use pediatric-inspired asparaginase-containing chemotherapy regimens in the management of ALL in adolesent/young adult and adult patients through this educational program featuring an expert-authored commentary, on-demand webcast, and downloadable slideset from a live symposium at ASH 2022, as well as a podcast on frequently asked questions.
Daniel J. DeAngelo, MD, PhD

ClinicalThought

In this commentary, a leukemia expert describes a best-case scenario for the use of an intensive chemotherapy regimen containing asparaginase in a 21-year-old woman with newly diagnosed acute lymphoblastic leukemia.

Daniel J. DeAngelo, MD, PhD Released: November 7, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Jazz Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings